Net Reclassification Improvement (NRI) and Clinical NRI for Various Endpoints for Baseline Troponin Assessed by Contemporary-Sensitivity, High-Sensitivity and Super-Sensitivity Assays in Addition to the Standard Framingham Risk Score.
<p>NRI = net reclassification improvement, clinical NRI = NRI for individuals with an intermediate 10-year risk (5–20%) according to the Framingham Risk Score, MACE = major adverse cardiac events, CVD = cardiovascular disease, MI = myocardial infarction, HF = heart failure, cs-cTnI = troponin I measured by contemporary-sensitivity assay, hs-cTnI = troponin I measured by high-sensitivity assay, ss-cTnI = troponin I measured by super-sensitivity assay, ns = not significant.</p
Medicine, cardiovascular, Acute cardiovascular problems, Heart failure, Myocardial infarction, stroke, Clinical research design, Cross-sectional studies, Diagnostic medicine, pathology, General pathology, biomarkers, epidemiology, Biomarker epidemiology, Cardiovascular disease epidemiology, reclassification, nri, endpoints, baseline, troponin, high-sensitivity, super-sensitivity, assays, framingham
DOI identifier: 10.1371/journal.pone.0090063.t004
Sorry, we are unable to provide the full text but you may find it at the